View in EDS

High Risk of Graft Rejection in Patients with HLA Homozygosity Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide.

Saved in:
Bibliographic Details
Title: High Risk of Graft Rejection in Patients with HLA Homozygosity Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide.
Authors: Jindal N; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Patel K; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Garg M; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Mirgh S; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Chichra A; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Nayak L; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Gokarn A; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Punatar S; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Bagal B; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Mathew LJ; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., D'Silva S; Transplant Immunology & Immunogenetics Lab (HLA), Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Singh M; Transplant Immunology & Immunogenetics Lab (HLA), Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India., Khattry N; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.
Source: Blood cell therapy [Blood Cell Ther] 2025 Feb 07; Vol. 8 (1), pp. 167-169. Date of Electronic Publication: 2025 Feb 07 (Print Publication: 2025).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Asia-Pacific Blood and Marrow Transplantation Country of Publication: Japan NLM ID: 9918333884906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2432-7026 (Electronic) Linking ISSN: 24327026 NLM ISO Abbreviation: Blood Cell Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40061176
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: High Risk of Graft Rejection in Patients with HLA Homozygosity Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jindal+N%22">Jindal N</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Patel+K%22">Patel K</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Garg+M%22">Garg M</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Mirgh+S%22">Mirgh S</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Chichra+A%22">Chichra A</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Nayak+L%22">Nayak L</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Gokarn+A%22">Gokarn A</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Punatar+S%22">Punatar S</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Bagal+B%22">Bagal B</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Mathew+LJ%22">Mathew LJ</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22D'Silva+S%22">D'Silva S</searchLink>; Transplant Immunology & Immunogenetics Lab (HLA), Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Singh+M%22">Singh M</searchLink>; Transplant Immunology & Immunogenetics Lab (HLA), Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Khattry+N%22">Khattry N</searchLink>; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918333884906676%22">Blood cell therapy</searchLink> [Blood Cell Ther] 2025 Feb 07; Vol. 8 (1), pp. 167-169. <i>Date of Electronic Publication: </i>2025 Feb 07 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Asia-Pacific+Blood+and+Marrow+Transplantation%22">Asia-Pacific Blood and Marrow Transplantation </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9918333884906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2432-7026 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224327026%22">24327026 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cell Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40061176
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.31547/bct-2024-024
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 167
    Titles:
      – TitleFull: High Risk of Graft Rejection in Patients with HLA Homozygosity Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jindal N
      – PersonEntity:
          Name:
            NameFull: Patel K
      – PersonEntity:
          Name:
            NameFull: Garg M
      – PersonEntity:
          Name:
            NameFull: Mirgh S
      – PersonEntity:
          Name:
            NameFull: Chichra A
      – PersonEntity:
          Name:
            NameFull: Nayak L
      – PersonEntity:
          Name:
            NameFull: Gokarn A
      – PersonEntity:
          Name:
            NameFull: Punatar S
      – PersonEntity:
          Name:
            NameFull: Bagal B
      – PersonEntity:
          Name:
            NameFull: Mathew LJ
      – PersonEntity:
          Name:
            NameFull: D'Silva S
      – PersonEntity:
          Name:
            NameFull: Singh M
      – PersonEntity:
          Name:
            NameFull: Khattry N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 02
              Text: 2025 Feb 07
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2432-7026
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cell therapy
              Type: main
ResultId 1